Curi RMB Capital
ONCE

Curi RMB Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Curi RMB Capital’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,077
Closed -$316K – 961
2018
Q4 		$316K Sell
8,077
-518
-6% -$22.5K 0.01% 730
2018
Q3 		$469K Hold
8,595
– – 0.01% 642
2018
Q2 		$711K Sell
8,595
-8,510
-50% -$657K 0.02% 568
2018
Q1 		$1.14M Sell
17,105
-6,243
-27% -$361K 0.03% 487
2017
Q4 		$1.2M Buy
23,348
+12,408
+113% +$891K 0.03% 455
2017
Q3 		$975K Buy
+10,940
New +$831K 0.03% 435

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Curi RMB Capital's ONCE Position: Q1 2019 in Review

Curi RMB Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 8,077 shares — an estimated $316K sold.

Curi RMB Capital first reported a position in ONCE in Q3 2017 and held it in 6 quarters. The position peaked at $1.2M in Q4 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Curi RMB Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Curi RMB Capital sold 8,077 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $316K.
  • Curi RMB Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
  • Curi RMB Capital's Spark Therapeutics, Inc. Common Stock position peaked at $1.2M in Q4 2017.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Curi RMB Capital's 13F filing for Q1 2019, filed 15 May 2019.